Drugs / Levophencynonate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02241629 | Aug → Dec 2014 | motion sickness | Sihuan Pharmaceutical Holdings Group Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT02299804 | Jan 2014 → May 2015 | — | Sihuan Pharmaceutical Holdings Group Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | levo phencynonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02241629 ↗ |
| Action | Inhibit | “this drug is M receptor inhibitor” NCT02299804 ↗ |